{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:04:34Z","timestamp":1791324274101,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T35 DK007386"],"award-info":[{"award-number":["T35 DK007386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.dld.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T18:13:29Z","timestamp":1649441609000},"page":"1179-1185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis"],"prefix":"10.1016","volume":"54","author":[{"given":"Kisan P.","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci","family":"Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Iuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1167-1101","authenticated-orcid":false,"given":"Evan S.","family":"Dellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dld.2022.03.006_bib0001","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O'Shea","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2022.03.006_bib0002","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2022.03.006_bib0003","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ajg.2014.316","article-title":"Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States","volume":"110","author":"Jensen","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2022.03.006_bib0004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MOG.0000000000000185","article-title":"Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences","volume":"31","author":"Eluri","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2022.03.006_bib0005","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1053\/j.gastro.2007.08.017","article-title":"Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment: sponsored by the American gastroenterological association (AGA) institute and North American society of pediatric gastroenterol","volume":"133","author":"Furuta","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2022.03.006_bib0006","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gutjnl-2015-310991","article-title":"Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis","volume":"65","author":"Molina-Infante","year":"2016","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.dld.2022.03.006_bib0007","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/ajg.2013.363","article-title":"Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.dld.2022.03.006_bib0008","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.cgh.2014.06.019","article-title":"Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study","volume":"12","author":"Dellon","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2022.03.006_bib0009","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2022.03.006_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo","year":"2017","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"10.1016\/j.dld.2022.03.006_bib0011","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","article-title":"Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.dld.2022.03.006_bib0012","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.cgh.2014.02.037","article-title":"Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor\u2013responsive esophageal eosinophilia but not eosinophilic esophagitis","volume":"12","author":"van Rhijn","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.03.006_bib0013","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jaci.2020.09.039","article-title":"Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors","volume":"147","author":"Rochman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.dld.2022.03.006_bib0014","doi-asserted-by":"crossref","unstructured":"Lucendo A.J., Arias \u00c1., Molina-Infante J. SYSTEMATIC REVIEWS AND META-ANALYSES efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Published online 2016. doi:10.1016\/j.cgh.2015.07.041","DOI":"10.1016\/j.cgh.2015.07.041"},{"issue":"11","key":"10.1016\/j.dld.2022.03.006_bib0015","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2015.314","article-title":"Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis","volume":"110","author":"Molina-Infante","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"May","key":"10.1016\/j.dld.2022.03.006_bib0016","first-page":"1","article-title":"Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry","author":"Laserna-Mendieta","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.dld.2022.03.006_bib0017","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.cgh.2009.08.030","article-title":"Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease","volume":"7","author":"Dellon","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2022.03.006_bib0018","doi-asserted-by":"crossref","first-page":"853","DOI":"10.14309\/ajg.0000000000000597","article-title":"Psychiatric comorbidities and psychiatric medication use are highly prevalent in patients with eosinophilic esophagitis and associate with clinical presentation","volume":"115","author":"Reed","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"10.1016\/j.dld.2022.03.006_bib0019","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.cgh.2019.03.009","article-title":"Combination therapy with elimination diet and corticosteroids is effective for adults with eosinophilic esophagitis","volume":"17","author":"Reed","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2022.03.006_bib0020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.gie.2015.11.019","article-title":"The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis","volume":"83","author":"Eluri","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2022.03.006_bib0021","article-title":"Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis","author":"Wolf","year":"2015","journal-title":"J Gastroenterol Hepatol Res"},{"key":"10.1016\/j.dld.2022.03.006_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.09.046","article-title":"Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: analysis of data from a prospective cohort study","author":"Reed","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.006_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.01.030","article-title":"A conceptual approach to understanding treatment response in eosinophilic esophagitis","author":"Dellon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.03.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.08.040","article-title":"Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment","author":"Dellon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.006_bib0026","article-title":"Dilation-predominant approach versus routine care in patients with difficult-to-treat eosinophilic esophagitis: a retrospective comparison","author":"Greenberg","year":"2021","journal-title":"Endoscopy"},{"issue":"6","key":"10.1016\/j.dld.2022.03.006_bib0027","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1038\/ctg.2017.27","article-title":"Diminishing effectiveness of long-term maintenance topical steroid therapy in PPI non-responsive eosinophilic esophagitis","volume":"8","author":"Eluri","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2022.03.006_bib0028","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2017.09.033","article-title":"Interchangeable use of proton pump inhibitors based on relative potency","volume":"16","author":"Graham","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2022.03.006_bib0029","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5056\/jnm18001","article-title":"Advantages and disadvantages of long-term proton pump inhibitor use","volume":"24","author":"Kinoshita","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2022.03.006_bib0030","article-title":"Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2022.03.006_bib0031","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-009-0951-9","article-title":"Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications","author":"Kedika","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.dld.2022.03.006_bib0032","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.dld.2021.05.025","article-title":"Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis","volume":"53","author":"Navarro","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.dld.2022.03.006_bib0033","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaip.2019.07.042","article-title":"Integration of a clinical scoring system in the management of eosinophilic esophagitis","volume":"8","author":"Ponda","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.dld.2022.03.006_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2018.00119","article-title":"The role of proton pump inhibitors in the management of pediatric eosinophilic esophagitis","volume":"6","author":"Guti\u00e9rrez-Junquera","year":"2018","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.dld.2022.03.006_bib0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cgh.2018.05.045","article-title":"Maintenance treatment of eosinophilic esophagitis with swallowed topical steroids alters disease course over a 5-year follow-up period in adult patients","volume":"17","author":"Greuter","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2022.03.006_bib0036","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dld.2022.03.006_bib0037","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.gastro.2016.11.021","article-title":"Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis","volume":"152","author":"Dellon","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dld.2022.03.006_bib0038","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cgh.2018.05.051","article-title":"Safety and efficacy of budesonide oral suspension maintenance therapy in patients with eosinophilic esophagitis","volume":"17","author":"Dellon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.006_bib0039","article-title":"Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial","author":"Hirano","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.006_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.03.060","article-title":"Long-term treatment of eosinophilic esophagitis with budesonide oral suspension","author":"Dellon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.dld.2022.03.006_bib0041","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ajg.2016.238","article-title":"Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis","volume":"111","author":"Andreae","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2022.03.006_bib0042","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10620-009-0859-4","article-title":"Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis","volume":"55","author":"Peterson","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.dld.2022.03.006_bib0043","article-title":"Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia","volume":"108","author":"Moawad","year":"2013","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"00","key":"10.1016\/j.dld.2022.03.006_bib0044","first-page":"1","article-title":"CYP2C19 and STAT6 variants influence the outcome of proton pump inhibitor therapy in pediatric eosinophilic esophagitis","volume":"00","author":"Mougey","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822002092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822002092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:20:08Z","timestamp":1761625208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822002092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1590865822002092"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.03.006","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}